These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 15582599)
1. ErbB2 overexpression in mammary cells upregulates VEGF through the core promoter. Loureiro RM; Maharaj AS; Dankort D; Muller WJ; D'Amore PA Biochem Biophys Res Commun; 2005 Jan; 326(2):455-65. PubMed ID: 15582599 [TBL] [Abstract][Full Text] [Related]
2. ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells. Klos KS; Wyszomierski SL; Sun M; Tan M; Zhou X; Li P; Yang W; Yin G; Hittelman WN; Yu D Cancer Res; 2006 Feb; 66(4):2028-37. PubMed ID: 16489002 [TBL] [Abstract][Full Text] [Related]
3. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2. Pedersen NM; Breen K; Rødland MS; Haslekås C; Stang E; Madshus IH Mol Cancer Res; 2009 Feb; 7(2):275-84. PubMed ID: 19208749 [TBL] [Abstract][Full Text] [Related]
4. The extracellular region of heregulin is sufficient to promote mammary gland proliferation and tumorigenesis but not apoptosis. Weinstein EJ; Leder P Cancer Res; 2000 Jul; 60(14):3856-61. PubMed ID: 10919660 [TBL] [Abstract][Full Text] [Related]
5. Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients. Junttila TT; Laato M; Vahlberg T; Söderström KO; Visakorpi T; Isola J; Elenius K Clin Cancer Res; 2003 Nov; 9(14):5346-57. PubMed ID: 14614020 [TBL] [Abstract][Full Text] [Related]
6. Selective hormone-dependent repression of estrogen receptor beta by a p38-activated ErbB2/ErbB3 pathway. St-Laurent V; Sanchez M; Charbonneau C; Tremblay A J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):23-37. PubMed ID: 15862947 [TBL] [Abstract][Full Text] [Related]
7. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network. Menendez D; Krysiak O; Inga A; Krysiak B; Resnick MA; Schönfelder G Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1406-11. PubMed ID: 16432214 [TBL] [Abstract][Full Text] [Related]
8. A negative feedback regulatory loop associates the tyrosine kinase receptor ERBB2 and the transcription factor GATA4 in breast cancer cells. Hua G; Zhu B; Rosa F; Deblon N; Adélaïde J; Kahn-Perlès B; Birnbaum D; Imbert J Mol Cancer Res; 2009 Mar; 7(3):402-14. PubMed ID: 19276186 [TBL] [Abstract][Full Text] [Related]
9. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. Zhang SX; Wang JJ; Gao G; Parke K; Ma JX J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919 [TBL] [Abstract][Full Text] [Related]
10. ErbB2 overexpression in p53-inactivated mammary epithelial cells. Yang JW; Lee EY; Kang KW FEBS Lett; 2006 Nov; 580(27):6501-8. PubMed ID: 17101136 [TBL] [Abstract][Full Text] [Related]
11. EGF stimulates Pit-1 independent transcription of the human prolactin pituitary promoter in human breast cancer SK-BR-3 cells through its proximal AP-1 response element. Manfroid I; Van de Weerdt C; Baudhuin A; Martial JA; Muller M Mol Cell Endocrinol; 2005 Jan; 229(1-2):127-39. PubMed ID: 15607537 [TBL] [Abstract][Full Text] [Related]
12. Dimethylarginine dimethylaminohydrolase 2 increases vascular endothelial growth factor expression through Sp1 transcription factor in endothelial cells. Hasegawa K; Wakino S; Tanaka T; Kimoto M; Tatematsu S; Kanda T; Yoshioka K; Homma K; Sugano N; Kurabayashi M; Saruta T; Hayashi K Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1488-94. PubMed ID: 16574895 [TBL] [Abstract][Full Text] [Related]
13. Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers. Yen L; Benlimame N; Nie ZR; Xiao D; Wang T; Al Moustafa AE; Esumi H; Milanini J; Hynes NE; Pages G; Alaoui-Jamali MA Mol Biol Cell; 2002 Nov; 13(11):4029-44. PubMed ID: 12429844 [TBL] [Abstract][Full Text] [Related]
14. Signal transducers and activators of transcription 3 up-regulates vascular endothelial growth factor production and tumor angiogenesis in head and neck squamous cell carcinoma. Masuda M; Ruan HY; Ito A; Nakashima T; Toh S; Wakasaki T; Yasumatsu R; Kutratomi Y; Komune S; Weinstein IB Oral Oncol; 2007 Sep; 43(8):785-90. PubMed ID: 17169602 [TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of rapamycin in a transgenic mouse model of ErbB2-dependent human breast cancer. Liu M; Howes A; Lesperance J; Stallcup WB; Hauser CA; Kadoya K; Oshima RG; Abraham RT Cancer Res; 2005 Jun; 65(12):5325-36. PubMed ID: 15958580 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity. Fujiwara M; Muragaki Y; Ooshima A Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401 [TBL] [Abstract][Full Text] [Related]
17. Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells. Cascio S; Ferla R; D'Andrea A; Gerbino A; Bazan V; Surmacz E; Russo A J Cell Physiol; 2009 Oct; 221(1):189-94. PubMed ID: 19492417 [TBL] [Abstract][Full Text] [Related]
18. Ectopic decorin expression up-regulates VEGF expression in mouse cerebral endothelial cells via activation of the transcription factors Sp1, HIF1alpha, and Stat3. Santra M; Santra S; Zhang J; Chopp M J Neurochem; 2008 Apr; 105(2):324-37. PubMed ID: 18021292 [TBL] [Abstract][Full Text] [Related]
19. VEGF is upregulated by hypoxia-induced mitogenic factor via the PI-3K/Akt-NF-kappaB signaling pathway. Tong Q; Zheng L; Lin L; Li B; Wang D; Huang C; Li D Respir Res; 2006 Mar; 7(1):37. PubMed ID: 16512910 [TBL] [Abstract][Full Text] [Related]
20. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A. Detwiller KY; Fernando NT; Segal NH; Ryeom SW; D'Amore PA; Yoon SS Cancer Res; 2005 Jul; 65(13):5881-9. PubMed ID: 15994966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]